By Reuters and TheMarker
Asseco Poland, Europe's fifth-biggest software group, is acquiring 51% of software group Formula Systems from Emblaze.
For Warsaw-listed Asseco, the acquisition provides an entry to new markets. For London-listed Emblaze, it represents a premium over Formula's present market cap.
Emblaze, a cellular technology group founded by embattled entrepreneur Eli Reifman, had bought the 33.6% controlling interest in Formula in 2006, to have a central revenue generator in the group. Later it increased its stake.
Emblaze said it could not turn down Asseco's offer, which priced Formula at 43% above its market cap. Emblaze said it would report a capital gain of about $35 million on the sale, which it would invest in its business and use to take advantage of opportunities in the market.
The deal, worth up to $145 million, follows Asseco's buying spree, which it used to more than double sales to nearly $1 billion in two years.
The deal remains contingent on approval by Emblaze shareholders, who will convene to discuss it before the end of November.
As of year-end 2008, Formula had paid its shareholders $30 million in dividends, of which Emblaze received $15 million. It spent most of that money developing a mobile phone ("else" ), which flopped. If the dividend is included in the calculation of returns on Emblaze's investment, then its return on Formula is 74%.
Reifman remains registered as a major shareholder at Emblaze, with 15.3% of its shares. However, there is doubt as to whether he has possession of the shares.
Formula earned $31 million last year on sales of $435 million. With the sale, Emblaze remains essentially bereft of a revenue driver.
The deal, worth up to $145 million, follows Asseco's buying spree, which it used to more than double sales to nearly $1 billion in two years.
The deal remains contingent on approval by Emblaze shareholders, who will convene to discuss it before the end of November.
As of year-end 2008, Formula had paid its shareholders $30 million in dividends, of which Emblaze received $15 million. It spent most of that money developing a mobile phone ("else" ), which flopped. If the dividend is included in the calculation of returns on Emblaze's investment, then its return on Formula is 74%.
Reifman remains registered as a major shareholder at Emblaze, with 15.3% of its shares. However, there is doubt as to whether he has possession of the shares.
Formula earned $31 million last year on sales of $435 million. With the sale, Emblaze remains essentially bereft of a revenue driver.
We have delayed publishing our September issue with the hope that the Israeli Palestine meeting in Washington will bring some fruits.
So far this has not been the case and the prospects a period of calm does not appear to be in the foreseeable future. Our scientific advisory board, copy chief, web master, graphics consultant, who designed the dove of peace, all wish our Jewish readers a Peaceful, Happy and Healthy New Year.